Munafa Stock Market Course + Intraday & FNO calls 
GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
GLENMARK NEWS reasons for why stock price of Glenmark Pharmaceuticals Limited is falling or rising
GLENMARK Glenmark Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast for Glenmark Pharmaceuticals Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Glenmark Pharmaceuticals GLENMARK at this time. Stock is falling and might fall more.
It appears as if Glenmark Pharmaceuticals GLENMARK gave a large move recently.
Stock of Glenmark Pharmaceuticals (GLENMARK) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.
My analysis of Glenmark Pharmaceuticals is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Glenmark Pharmaceuticals stays below 2278.4, but if it comes above 2278.4, then a intra day buy could be more profitable.
If you take a sell trade below 2278.4, then use 2278.4 as stoploss and 2218.6 as target. However if you take a buy trade in Glenmark Pharmaceuticals, then use 2278.4 as stoploss and 2328.14 as target.
GLENMARK Glenmark Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 20, 2026, titled "Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting - NEWS as on 2026-05-20
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2026-05-20
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 18, 2026, titled "Glenmark Pharmaceuticals Inc., USA Launches Vancomycin Hydrochloride for Injection USP, 500 - NEWS as on 2026-05-18
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 09, 2026, titled "Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg". - NEWS as on 2026-04-09
Company Announcement Glenmark Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. - NEWS as on 2026-04-06
Company Announcement Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory action/ inspection - NEWS as on 2026-04-02
Company Announcement Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325. - NEWS as on 2026-03-23
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch - NEWS as on 2026-03-16
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Compet - NEWS as on 2026-03-04
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, - NEWS as on 2026-02-27
More announcements and NEWS
GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals
Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 22 Fri May 2026 | 2259.10 | 2226.30 to 2413.90 | -5.6% | 2.22 times |
| 21 Thu May 2026 | 2393.00 | 2372.00 to 2407.80 | 0.59% | 0.53 times |
| 20 Wed May 2026 | 2379.00 | 2370.00 to 2427.00 | -1.12% | 1.36 times |
| 19 Tue May 2026 | 2405.90 | 2335.00 to 2413.50 | 2.82% | 1.19 times |
| 18 Mon May 2026 | 2339.90 | 2301.00 to 2353.30 | 0.6% | 0.6 times |
| 15 Fri May 2026 | 2325.90 | 2317.10 to 2367.90 | -0.63% | 0.36 times |
| 14 Thu May 2026 | 2340.60 | 2292.60 to 2350.40 | 2.77% | 1.35 times |
| 13 Wed May 2026 | 2277.60 | 2245.20 to 2326.50 | 0.91% | 1.41 times |
| 12 Tue May 2026 | 2257.10 | 2244.00 to 2340.90 | -3.84% | 1.06 times |
| 11 Mon May 2026 | 2347.30 | 2317.70 to 2368.80 | -0.81% | 1.16 times |
| 08 Fri May 2026 | 2366.40 | 2315.80 to 2384.90 | -0.22% | 0.98 times |
| 07 Thu May 2026 | 2371.60 | 2355.70 to 2404.00 | -0.25% | 0.59 times |
Videos related to: GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
